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Background: Even though dengue has been recognized as one of the major public health threats in Pakistan, the
understanding of its molecular epidemiology is still limited. The genotypic diversity of Dengue virus (DENV)
serotypes involved in dengue outbreaks since 2005 in Pakistan is not well studied. Here, we investigated the origin,
diversity, genetic relationships and geographic distribution of DENV to understand virus evolution during the recent
expansion of dengue in Pakistan.
Methods: The study included 200 sera obtained from dengue-suspected patients from 2006 to 2011. DENV
infection was confirmed in 94 (47%) sera by a polymerase chain reaction assay. These included 36 (38.3%) DENV-2,
57 DENV-3 (60.6%) and 1 DENV-4 (1.1%) cases. Sequences of 13 whole genomes (6 DENV-2, 6 DENV-3 and 1 DENV-4)
and 49 envelope genes (26 DENV-2, 22 DENV-3 and 1 DENV-4) were analysed to determine the origin, phylogeny,
diversity and selection pressure during virus evolution.
Results: DENV-2, DENV-3 and DENV-4 in Pakistan from 2006 to 2011 shared 98.5-99.6% nucleotide and 99.3-99.9%
amino acid similarity with those circulated in the Indian subcontinent during the last decade. Nevertheless, Pakistan
DENV-2 and DENV-3 strains formed distinct clades characterized by amino acid signatures of NS2A-I116T + NS5-K861R
and NS3-K590R + NS5-S895L respectively. Each clade consisted of a heterogenous virus population that circulated in
Southern (2006–2009) and Northern Pakistan (2011).
Conclusions: DENV-2, DENV-3 and DENV-4 that circulated during 2006–2011 are likely to have first introduced via the
southern route of Pakistan. Both DENV-2 and DENV-3 have undergone in-situ evolution to generate heterogenous
populations, possibly driven by sustained local DENV transmission during 2006–2011 periods. While both DENV-2 and
DENV-3 continued to circulate in Southern Pakistan until 2009, DENV-2 has spread in a Northern direction to establish
in Punjab Province, which experienced a massive dengue outbreak in 2011.
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Dengue is an acute febrile illness with a clinical spectrum
of mild flu-like illness (dengue fever or DF) to fatal com-
plications of severe dengue hemorrhagic fever (DHF) and
dengue shock syndrome (DSS). The disease is caused by
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reproduction in any medium, provided the orgenetically and immunogenically distinct serotypes. DENV
is a single stranded positive sense RNA virus with a 11.8
kb genome flanked by 5’ and 3’ untranslated regions and a
single coding region for three structural proteins: capsid
(C), the precursor of membrane (prM) and envelope (E);
and seven nonstructural proteins: NS1, NS2A, NS2B,
NS3, NS4A, NS4B and NS5 [1].
DENV is transmitted to humans through the bites of
infected female mosquitoes of Aedes aegypti and Ae.
albopictus. The transmission of DENV has increased in
recent years in urban and semi-urban endemic settings,
especially in Americas, South and South-east Asia and
the Western Pacific. The magnitude, distribution, and. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ingly high in countries such as India [2], Sri Lanka [3],
Nepal [4] Bangladesh [5] and Pakistan [6] in the Indian
subcontinent during the last decade.
Pakistan is endemic to all four serotypes of DENV cir-
culating throughout the year with a peak incidence dur-
ing the post monsoon period between October and
December [7,8]. Factors such as crowded cities, unsafe
drinking water, inadequate sanitation and large number
of refugees facilitate the spread of dengue in different
parts of the country, resulting in increased morbidity
and mortality. It is believed that DENV was first intro-
duced into Pakistan through the importation of tyres
containing eggs of infected mosquitoes at Karachi sea
port [9]. Although serological evidence of DENV infec-
tions in Pakistan dates back to 1968 [10], the first con-
firmed outbreak associated with DHF occurred in the
southern Pakistan city of Karachi in 1994 [11]. Sero-
logical studies confirmed the circulation of both DENV-1
and DENV-2 during the 1994 outbreak [12]. Since then,
the disease has emerged as a major public health problem
in the country [13]. DENV-3 was first reported during the
2005–2006 outbreak in Karachi [14,15]. By 2007, dengue
started to emerge in the Northern Pakistan. DENV-2 and
DENV-3 have been the dominant serotypes in Lahore
from 2007 to 2009 [16]. Dengue showed a resurgence in
November 2010, especially in Sindh, Punjab and Khyber
Pakhtunkhwa regions subsequent to massive floods in July
same year [6]. The outbreak escalated in Lahore, Punjab,
in 2011 with 22,562 cases and 363 deaths due to severe
DHF [6].
So far, there have been a few, comprehensive molecu-
lar epidemiological studies that describe DENV circulat-
ing in Pakistan. There is only one genome-wide analysis
that describes Pakistani DENV-2 circulated during the
2011 outbreak [17]. The studies of molecular epidemi-
ology and evolutionary genetics are important to predict
the origin and spread of viruses, to strengthen our un-
derstanding on the pathogenesis of disease, the cause of
epidemics and the genetic basis of virulence. RNA vi-
ruses such as DENV evolve rapidly [18] and on rare oc-
casions, certain mutations lead to phenotypic changes in
the viruses that alter their potential to cause outbreaks
associated with severe disease [19]. Genotypic charac-
terization has been a useful tool in determining the evolu-
tionary origin of the DENV, identifying the circulating
virus strains in an endemic area and detecting the intro-
duction of new genotypes. In recent years, envelope (E)
gene sequencing has been widely used to assess the phylo-
genetic relationships among DENV isolates [20]. In
Pakistan, sequencing of NS3 gene [21] and C-prM gene
[14,16] junction has mainly been used for the genetic ana-
lyses of DENV. Khan and co-workers recently performed
a more comprehensive analysis of DENV2 strainsassociated with 2011 outbreak in Lahore [17]. Neverthe-
less, the use of relatively short (up to 400 bp) and small
number of sequences in available studies have limited the
resolution of phylogenetic analyses aimed at determining
the origin and evolution of DENV in Pakistan during the
last decade.
Therefore, in the present study, we conducted a de-
tailed molecular characterization of Pakistan DENV
strains using the complete E gene and whole genome
analyses. DENV isolates obtained from different parts of
Pakistan between 2006 and 2011 were studied, in order
to obtain a temporal evolutionary perspective of DENV
in the country over a 6-year period. We describe the
likely origin, evolution and geographic distribution of
DENV that explain the recent changes of dengue epi-
demiology in Pakistan.
Results and discussion
Out of 200 sera analysed, 94 (47%) were positive for
DENV by polymerase chain reaction (PCR). These in-
cluded 36 DENV-2 (38.3%), 57 DENV-3 (60.6%) and 1
DENV-4 (1.1%) cases (Table 1). None of the samples
was positive for DENV-1. DENV could be isolated only
from 25 PCR-positive sera (26.6%). These included 12
DENV-2 (48.0%), 12 DENV-3 (48.0%) and 1 DENV-4
(4.0%) cases. The reduced success rate of virus isolation
in PCR positive sera is due to collection of the majority
of sera during the late viraemic phase and further reduc-
tion in virus titres during long-term storage, transfer
and freeze-thawing of samples. Among the DENV-2
samples, 7 were classified as DF, 16 as DHF and 3 as
DSS, whereas for DENV-3, there were 18 DF and 4 DHF
cases. Only 1 DENV-4 sample classified as DF was in-
cluded in this study (Additional file 1).
We detected only DENV-3 among sera collected dur-
ing the 2006–2007 periods, whereas DENV-2, DENV-3
and DENV-4 were observed in sera collected after 2008.
This is in agreement with previous findings that DENV-2
became dominant during the 2007–2009 periods [16]. The
absence of DENV-1 in our cohort was not surprising as it
has not been documented in Pakistan between 2006 and
2009 [9,16] and was a minor serotype in 2010 in Northern
parts of the country [22]. During the 2006–2009 periods,
87.7% (n=71) of analysed sera were collected in Karachi,
the capital of Sindh province in Southern Pakistan. On the
other hand, 69.2% (n=9) of cases in 2011 were from La-
hore in Punjab province of the Northern Pakistan where a
major dengue outbreak was reported in the same year.
This case distribution pattern reflects the dengue epidemi-
ology in Pakistan, where the disease was initially restricted
to the southern part of the country, particularly the port
city of Karachi, and subsequently expanded to the north,
causing major epidemics. The spread of dengue to other
parts of the country is believed to be either due to the











DENV-1 DENV-2 DENV-3 DENV-4
2006 97 46 0 0 46 0
2007 3 3 0 0 3 0
2008 8 4 0 2 2 0
2009 61 28 0 21 6 1
2011 30 13 0 13 0 0
Unknown 1 0 0 0 0 0
Total 200 94 0 36 57 1
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carrying vertically-transmitted DENV from dengue-affected
areas [6].
In order to understand the origin and evolution of dif-
ferent DENV serotypes during their spread in Pakistan,
we performed a detailed analysis of 13 full genomes (6
DENV-2, 6 DENV-3 and 1 DENV-4) and 49 envelope
(E) gene sequences detected in Southern and Northern
parts during the 2006–2011 period. All E gene se-
quences were obtained directly from PCR-positive sera
and comprised 26 DENV-2, 22 DENV-3 and 1 DENV-4
strains. Full genome sequencing was performed on vi-
ruses isolated from sera.
Characteristics of DENV-2 in Pakistan
Phylogenetic analysis of 26 DENV-2 E gene sequences
obtained between 2008 and 2011 revealed that all viruses
belonged to Indian subcontinent lineage of the cosmo-
politan genotype. Although there were more DHF com-
pared to DF among the samples collected, there was no
unique signature in the E gene sequences that could dif-
ferentiate between DF and DHF/DSS samples. With the
exception of 1 isolate (D2-PS51) that was closely related
to a previous strain from Saudi Arabia, the remaining 25
isolates formed a distinct monophyletic clade with 78%
bootstrap support (Figure 1). In DENV-2 whole genome
analysis, the same clade achieved 100% bootstrap sup-
port, strengthening the credibility of the clade further
(data not shown). This monophyletic clade included
DENV-2 isolates obtained from 14 sera collected in
Southern Pakistan (Karachi) in 2008 and 2009 as well as
11 sera collected in Northern Pakistan in 2011. Among
complete E gene sequences available in GenBank data-
base, these 25 viruses shared the highest nucleotide
(98.8-99.5%) and amino acid (99.5-100%) similarity with
those reported from Sri Lanka [GenBank: GQ252676
and GQ252677] and India [GenBank: DQ448231] during
the 2003–04 periods. The nucleotide (99.1-99.4%) and
amino acid (99.7-99.9%) similarity was even higher at
whole genome level between Pakistan and 2003–2004Indian/Sri Lankan strains. Furthermore, whole genome
analysis revealed a unique combination of 8 amino acid
substitutions that was shared between the monophyletic
clade of Pakistan DENV-2 and Indian/Sri Lankan iso-
lates (Table 2). These findings indicated the close genetic
relationship among DENV-2 strains circulated in the In-
dian subcontinent during the last decade. Even though
the earliest DENV-2 isolate of our study cohort was in
2008, estimation of time to the most recent common an-
cestor (TMRCA) dated the origin of Pakistan DENV-2
clade to early 2006 [95% highest probability density
(HPD) 2004.5 – 2007.4]. Given the fact that genetically
similar strains existed in the region even in 2003, it is
likely that the 2008–2011 clade of Pakistan DENV-2 vi-
ruses descended from an ancestral strain that was previ-
ously circulating in other parts of the Indian subcontinent
region. Further evolution in subsequent years has deviated
Pakistan DENV-2 from its common ancestor to form a
monophyletic clade by 2008. During this process, Pakistan
DENV-2 strains have acquired 2 additional fixed amino
acid substitutions (NS2A-I116T and NS5-K861R), of
which NS5-K861R is unique to Pakistan strains (Table 2).
In DENV-2, residue NS5-861 is a strictly conserved Ly-
sine. NS5-861 resides in the “thumb” domain of the C-
terminal end of RNA dependent RNA polymerase (RdRp)
of DENV [23]. This residue sits outside structural ele-
ments of thumb domain that form the RNA template tun-
nel (residues 740–747 and 782–809) and a zinc binding
site (residues 712, 714, 728 and 847). Therefore, even
though the functional implications of the Lysine to Argin-
ine substitution in our isolates are not clear, major struc-
tural changes are not expected as the K861R substitution
does not alter the amino acid properties at the residue.
Furthermore, our findings indicated an in-situ spatio-
temporal evolutionary pattern of Pakistan DENV-2 dur-
ing the period from 2008 to 2011. This was evident by
the step-ladder pattern topology of the 2008–2011
Pakistan clade (Figure 1), in which the 2009 viruses in
Southern Pakistan were ancestral to the distinct sub-
clade (99% bootstrap support) formed by 2011 viruses in
the North. This 2011 sub-clade possessed a unique sub-
stitution (prM-S70A) that was shown to be under the di-
versifying selection (p=0.05, Table 2) by the mixed effect
model of evolution (MEME) method. In contrast, single
likelihhod ancestor counting (SLAC), fixed effects likeli-
hood (FEL) [27] and internal fixed effects likelihood
(IFEL) [28] methods showed the same residue to be
under purifying selection. MEME is one of the methods
available in Hyphy package to perform the codon-based
selection pressure analysis [29]. A simulation study using
MEME has shown that MEME is preferable to other
methods as it is capable of identifying not only pervasive
positive selection at the level of an individual site, but
also episodic (transient) positive selection affecting only
Figure 1 Phylogenetic tree of DENV-2. The maximum-likelihood tree was constructed based on the complete envelope gene sequences
generated during this study and retrieved from GenBank. Sequences from Pakistan are highlighted in red. Figures on branches are bootstrap
percentages. Only bootstrap values more than 75% are shown on the major nodes.
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missed by other methods that rely on the mean non-
synonymous to synonymous ratio (dN/dS) over a period
of time [31]. Sequences from another recent study [17]
have also shown prM-S70A to be fixed and unique to
isolates from Lahore in 2011. Therefore, we postulate
that amino acid residue prM-70 is likely to have been se-
lected for during the DENV-2 outbreak in Northern
Pakistan in 2011. As the support for diversifying selec-
tion in MEME analysis is marginally significant (p=0.05)
and we obtained contrasting outputs from SLAC, FEL
and IFEL methods, it is difficult to conclude whether the
fixation of prM-S70A among Pakistani DENV-2 strains
is either due to positive selection or genetic drift. Never-
theless, codon 70 constitutes the variable, middle amino
acid residue of the N-glycosylation site sequon (N-S-T)
of DENV-2 prM protein [1]. N-glycosylation of prMprotein is believed to play an important role in virion as-
sembly and transport before release [1]. The prM-70
residue is a strictly-conserved Serine in human DENV-2
isolates, except for two sylvatic viruses (N-A-T) reported
from Malaysia in 2008 [24] and 1970 [25]. Therefore,
whether this substitution from a hydrophilic Serine to a
hydrophobic Alanine at prM-70 residue alters the con-
formation and thereby the functionality of the N-
glycosylation site providing a selective advantage to DENV
is of interest and necessitates further investigation.
As illustrated in Figure 1, virus populations from
Southern and Northern areas are heterogenous, indicat-
ing the possibility of sustained virus transmission in both
areas driving the viral diversity. While the majority of
2011 viruses belonged to a distinct clade, some remained
within a 2009 virus cluster (Figure 1). Based on these
observations, it is likely that DENV-2 first expanded in











Other reports of similar substitutions Mixed effect model of evolution (MEME)
analysis
α β- q- β+ P value Log L
130 prM 16 R K Sri Lanka2003-04§ & Pakistan [17] 1.87 0 0.97 91.05 0.15 −35.52
184 prM 70 S A Pakistan£ [17] & Malaysia (sylvatic) [24,25] 3.61 0 1 134.67 0.05 −41.97
862 NS1 87 T S Sri Lanka2003-04§ 1.25 0 0.97 6.49 0.74 −27.76
1160 NS2A 33 I V India2001-06§ & Sri Lanka 1996-2004§ 0 1 0.06 0.33 0.66 −13.61
1243 NS2A 116 I T Thailand 1984 [26] 0 0 0.6 2.7 0.42 −40.58
2891 NS5 400 T A Sri Lanka 2003-04§ 0 0 0.93 2.85 0.48 −10.8
2953 NS5 462 L I India2001-06§ & Sri Lanka 1996-04§ 1.12 0 0.99 513.74 0.20 −38.62
3107 NS5 616 E G India2001-06§ & Sri Lanka 1996-2004§ 0 1 0.62 0.85 0.44 −9.39
3122 NS5 631 S G India2001-06§ & Sri Lanka 1996-2004§ 0.35 0.45 0.16 1.44 0.23 −32.15
3352 NS5 861 K R Unique to Pakistan£ 0 0 0.98 20.75 0.26 −11.06
3367 NS5 876 N S India2001-06§ & Sri Lanka 1996-04§ 0 0 0.98 19.81 0.19 −11.44
§Directly obtained from the GenBank database.
£Reported in this study.
Mutations under positive selection and those that are unique to Pakistan DENV-2 isolates are shown in bold.
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Northern region where certain sub-population/s evolved
further to become a distinct viral population in 2011.
Therefore, the overall epidemiological understanding of
South to North expansion of dengue in Pakistan is sup-
ported by our genetic analysis of DENV-2.
Characteristics of DENV-3 in Pakistan
The emergence of DENV-3 in Pakistan was first
reported during the 2005 DHF outbreak in Karachi [14].
Previous studies have revealed that DENV-3 sequences
from the 2005 and 2006 outbreaks were most closely re-
lated to those circulating in India [14,32] and belonged
to genotype III [16]. In support, all 22 DENV-3 E gene se-
quences from our study also belonged to the genotype III
(Figure 2). Furthermore, all of our study isolates that were
collected in southern Pakistan (Karachi and Hyderabad)
from 2006 to 2009 shared the highest genetic similarity
with two Indian DENV-3 strains [GenBank: AY770511
and FJ644564] and one Chinese strain [GenBank:
GU363549]. Of these, one of the Indian strains [GenBank:
AY770511] was reported in 2003 [32] whereas the
remaining Indian [33] and Chinese strains were reported
in 2007 and 2009 respectively. Therefore, it was evident
that ancestral strains of Pakistan DENV-3 were present in
the Indian subcontinent before their emergence in
Pakistan during the 2005–2006 periods. At E gene level,
nucleotide and amino acid similarities between the
Pakistan and the Indian strain in 2003 [GenBank:
AY770511] were 98.8-99.2% and 99.5-100%, respectively.
The respective whole genome similarities between
Pakistan DENV-3 isolates (n=6) and the same Indian
strain were 98.9-99.2% (nucleotide) and 99.6-99.8% (aminoacid). Sharing of a unique combination of 4 amino acid
substitutions (NS1-L178M, NS4B-M151I, NS5-T188A
and NS5-Q562L) between Pakistan and Indian isolates
(Table 3) further supported the previous notion that
Pakistan DENV-3 isolates are genetically related to those
circulating in India in preceding years. Of these, NS1-
L178M was found to be a positively selected site (p: <0.01.
Table 3) in the MEME-based selection pressure analysis,
suggesting a lineage-specific selective advantage of DENV-3
that circulated in the Indian subcontinent before 2009.
SLAC, FEL and IFEL-based slection pressure analyses pre-
dicted the same site to be neutral. The residue 178 sits in
domain II of flavivirus NS1 protein [34], adjacent to one
of the 12 strictly conserved Cysteine residues (DENV-3-
Cys179) that form disulfide linkages [1]. Disulfide bridges
are believed to play an important role in NS1 dimerization
[35]. Interestingly, residue 178 appears to follow a lineage-
specific variability as DENV-3 genotype III lineage in
South-east Asia (Vietnam, Cambodia, Thailand) shows a
fixed NS1-L178S substitution. This observation, together
with our data, indicates the likelihood of episodic diversi-
fying selection at DENV-3 NS1-178 residue, as predicted
by the MEME analysis for positive selection pressure.
Overall, these findings suggested an Indian subcontin-
ent ancestry of 2006–2009 Pakistan DENV-3. Interest-
ingly, E gene-based TMRCA analysis dated the origin of
2006–2009 Pakistan DENV-3 to late 2002 (95% HPD
2001.6-2004.0). The available evidence of a genetically
closest Indian DENV-3 isolate in 2003, therefore, con-
firms the circulation of similar virus strains in other
parts of the Indian subcontinent at the time of emer-
gence of the common ancestor of the 2006–2009
DENV-3 strains in Pakistan. However, despite their high
Figure 2 Phylogenetic tree of DENV-3. The maximum-likelihood tree was constructed based on the complete envelope gene sequences
generated during this study and retrieved from GenBank. Sequences from Pakistan are highlighted in red. Figures on branches are bootstrap
percentages. Only bootstrap values more than 75% are shown on the major nodes.
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DENV-3 formed a distinct E gene cluster with 76% boot-
strap support (Figure 2). In DENV-3 whole genome
phylogeny, the bootstrap support of the same clade im-
proved to 100% (data not shown). Our whole genome
analysis revealed that this genetic deviation of Pakistan
strains from Indian sub continent isolates was driven by
two additional fixed amino acid substitutions (NS3-
K590R and NS5-S895L). Of these, NS3-K590R is unique
to Pakistan DENV-3 isolates. NS3-K590R falls within a
loop structure between alpha helices 9 and 10 offlavivirus helicase domain 3 [36]. Even though domain 3
does not house major functional elements of helicase ac-
tivity, it contributes to structural stability and the forma-
tion of RNA binding cleft [36-39]. Domain 3 is also
believed to act as the RNA-dependent RNA polymerase
binding site [36]. As the residue 590 does not carry any
known structural significance, the effect of NS3-K590R
substitution on the domain 3 functionality of our study
isolates is unclear. In summary, our analysis indicates
that 2006 DENV-3 strains emerged from an ancestral
strain that introduced into Southern Pakistan, possibly










Other reports of similar substitutions Mixed effect model of evolution (MEME)
analysis
α β- q- β+ P value Log L
951 NS1 178 L M India 2003–07 [32,33] & China 2009§ 1.83 0.36 0.99 1844.02 <0.01 −53.95
2063 NS3 590 K R Unique to Pakistan£ 1.28 0 0.98 42.42 0.58 −17.20
2393 NS4B 151 M I India 2003–07 [32,33] & China 2009§ 1.35 0.16 1.00 0.31 1.00 −9.87
2678 NS5 188 T A India 2003–07 [32,33], China 2009§,
Venezuela 2001-07§, Puerto Rico 2006§
0.85 0.38 0.99 707.57 0.21 −35.65
3052 NS5 562 Q L India 2003–07 [32,33], China 2009§, Colombia 2004§ 1.74 1.00 0 2.65 0.64 −33.19
3385 NS5 895 S L Puerto-Rico 2002-03§, Colombia 2003§,
Vietnam 2006§
2.00 0 0.99 35.8 0.47 −21.96
§Directly obtained from the GenBank database.
£Reported in this study.
Mutations under positive selection and those that are unique to Pakistan DENV-3 isolates are shown in bold.
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evolved further to emerge as a distinct clade during the
outbreak in Karachi in 2006.
Characteristics of DENV-4 in Pakistan
DENV-4 was first reported in Lahore during the 2008
dengue outbreak in Punjab, Pakistan [40]. Phylogenetic
analysis showed that DENV-4 from the Indian subcontin-
ent formed a distinct group within genotype I (Figure 3).
A DENV-4 isolate obtained from Karachi in 2009 during
our study clustered with another Pakistan sequence
reported previously in the same year [41]. These Pakistan
isolates shared the highest nucleotide (98.5%) and amino
acid (99.3%) with a DENV-4 strain (GenBank: HM237349)Figure 3 Phylogenetic tree of DENV-4. The maximum-likelihood tree wa
generated during this study and retrieved from GenBank. Sequences from
percentages. Only bootstrap values more than 75% are shown on the majofrom Andra Pradesh in Southren India in 2007 [42].
Therefore, it is evident that DENV-4 strains closely related
to those in Pakistan in 2009 have previously been circulat-
ing in the Indian subcontinent. Nevertheless, more se-
quence data from a wider geographical scale in the Indian
subcontinent region is needed to confirm the spread and
evolutionary history of DENV-4 in Pakistan.
Conclusions
DENV-2, DENV-3 and DENV-4 have co-circulated in
Pakistan from 2008 to 2011. All three serotypes in
Pakistan share an Indian subcontinent ancestry and are
likely to have been introduced first into Southern
Pakistan. DENV-2 and DENV-3 have undergone in situs constructed based on the complete envelope gene sequences
Pakistan are highlighted in red. Figures on branches are bootstrap
r nodes.
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ulations during the same period. While both DENV-2
and DENV-3 continued to circulate in Southern
Pakistan until 2009, DENV-2 has subsequently spread in
a Northern direction, a move that caused a massive out-
break in Punjab province in 2011. The study, therefore,
highlights the implication of human migration and virus
evolution in the expansion of dengue to areas where the
disease was not previously a major public health threat,




Aga Khan University Hospital (AKUH) is a 550 bed ter-
tiary care hospital located in Karachi, Pakistan. The hos-
pital is equipped with a state of the art clinical
laboratory that caters not only for the in-patients but
also reaches out to the community. It has a unique net-
work of 200 sample collection units spread throughout
the country. The laboratory receives samples from inpa-
tients and outpatients of AKUH and from other clinics
and hospitals in all major cities of the country. Karachi
witnessed its first ever severe dengue outbreak in 2005–
06 during which the clinical laboratory of AKUH was at
the forefront of dengue diagnosis.
The patients presenting to the clinics and in-patients
of the AKUH Karachi, with the history of fever, head-
ache, joint pain, vomiting and diarrhoea were recruited
based on presumptive clinical diagnosis of DENV infec-
tion. In addition, samples obtained from out patients at
collection units were also included. After taking in-
formed consent, a complete Performa about patient’s
demographics and clinical presentation were filled.
Serum samples of each patient were stored in three ali-
quots at −80°C. Two hundred dengue-suspected sera
collected from 2006 to 2011 were retrieved from the
serum bank at AKUH and were shipped to Environmen-
tal Health Institute, National Environment Agency,
Singapore for the molecular epidemiological analysis.
The work presented here was approved by the Ethical
Review Committee, Aga Khan University (AKU), Pakistan.
Virus isolation
DENV was isolated from sera using the Ae. albopictus
clone C6/36 mosquito cell line (ATCC CRL-1660).
Briefly, the monolayer of C6/36 was inoculated with
serum in L-15 maintenance medium containing 3 % FCS
at 33°C to allow for virus adsorption and replication.
The infected fluid was harvested after 5–10 days. The
presence of DENV in cell supernatants was confirmed
by an immunofluoresent assay (IFA) during which cells
were reacted with either DENV group-specific or
serotype-specific monoclonal antibodies derived fromhybridoma cultures (ATCC HB-46, HB-47, HB-48, and
HB-49). The fluorescein isothiocyanate-conjugated goat
anti-mouse antibody was used as the detector. A max-
imum of three passages was done for each sample based
on the original virus load.
RNA extraction and conventional PCR for detection and
serotyping of Dengue virus
Viral RNA was extracted either from sera or culture su-
pernatants using the QIAGEN QIAamp viral RNA
minikit (QIAGEN, Hilden, Germany) according to the
manufacturer’s recommendations.
Conventional semi-nested PCR was performed using a
modified procedure described by Lanciotti and col-
leagues [43]. A one-step RT-PCR was performed using
the AccessQuickTM RT-PCR System (Promega, Madison,
WI, USA) in a 50 μl reaction volume containing 1X
AccessQuick TM Master Mix, 2.5 units of AMV Reverse
Transcriptase and 0.25 μM (each) of Primers D1 and D2
[43]. The reactions were carried out in Tgradient PCR
Thermocycler (Biometra, Gottingen, Germany) using the
following programme; reverse transcription at 45°C for
30 min, inactivation at 94°C for 2 min, and PCR amplifi-
cation of 40 cycles under the following conditions: 94°C
for 30 sec, 55°C for 30 sec, 72°C for 1 min, and a final
extension at 72°C for 5 min. Five microlitres of the
1:100 dilution of the first-round PCR product was fur-
ther amplified in a 50 μl reaction mixture containing 1X
Green GoTaq® Flexi Buffer, 1.5 mM MgCl2, 0.2 mM
dNTPs, 1.25 units of GoTaq® DNA Polymerase (Promega,
Madison, WI, USA) and 0.5 μM of each primer D1, TS1,
TS2, TS3 and TS4 [43]. After denaturation at 95°C for 2
min, the second round amplification was performed for 30
cycles (95°C for 30 sec, 55°C for 30 sec, 72°C for 1 min,
and a final extension at 72°C for 10 min). Amplified prod-
ucts were visualized in 2% agarose gels stained with
GelRed (Biotium Inc., USA).
PCR amplification of envelope gene for sequencing
The synthesis of complementary DNA (cDNA) from RNA
extracted from sera was carried out using Superscript™ III
First-strand Synthesis System (Invitrogen, Carlsbad, USA).
The complete envelope (E) gene (~1.5 kb) was amplified
by PCR using 0.5 μM of DENV serotype-specific primers
(Additional file 2) and 1X Phusion™ Flash High-Fidelity
PCR Master Mix (Finnzymes, Lafayette, CO). The amplifi-
cation protocol is as follows: initial denaturation at 98°C
for 5 sec, 35 cycles of denaturation at 98°C for 5 sec,
annealing at 60°C for 8 sec, extension at 72°C for 25 sec
and final extension at 72°C for 1 min. Semi-nested PCR
(~1.4 kb, Additional file 2) was performed as above if no
desired product yielded in the first-round amplification.
Amplified products were visualized in 2% agarose gels
stained with GelRed (Biotium Inc., USA).
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A total of 13 DENV isolated from DENV-2 (n=6),
DENV-3 (n=6) and DENV-4 (n=1) positive sera were se-
lected for full genome sequencing. Isolates were selected
to represent different groups of viruses based on E gene
phylogeny. Amplification and sequencing primers were
designed to cover the entire genome of different serotypes
in overlapping fragments (Additional files 3, 4 and 5).
Additional two sets of primers (Additional file 6) were
used to capture 5' and 3' untranslated regions of complete
genome for all four DENV serotypes. The PCR reaction
was performed using the Phusion™ Flash High-Fidelity
PCR Master Mix (Finnzymes, Lafayette, CO) as described
for E gene amplification. Amplified products were visu-
alized in 2% agarose gels stained with GelRed (Biotium
Inc., USA).
Purification and sequencing of PCR products
PCR products were purified using the Qiaquick PCR
Purification kit (Qiagen, Hilden, Germany) according to
manufacturer’s instructions. Sequencing of purified PCR
products was perfromed by a commercial sequencing
company (AITbiotech Pte Ltd, Singapore) according to
the BigDye Terminator Cycle Sequencing kit (Applied
Biosystems, USA) protocol. Seqeunces were deposited in
Genbank database under the accession numbers KF041212 -
KF041260.
Phylogenetic and mutation analyses of envelope genes
and complete genomes
Nucleotide sequences were assembled using the Lasergene
package version 8.0 (DNASTAR Inc., Madison, WI, USA).
Contiguous sequences were aligned using ClustalX pro-
gram [44] and compared with published sequences of
DENV isolates in Genbank database. Phylogenetic analysis
of E gene sequences was performed in MEGA5 program
[45] using the maximum-likelihood method based on the
general time reversible (GTR) model with gamma distri-
bution and invariant sites. The robustness of the original
tree was tested with 1000 bootstrap replications. Compari-
son of amino acid sequences deduced from nucleotide
alignments was performed by using the BioEdit v7.0.5
software to identify unique mutations in study isolates.
Estimation of the time of viral emergence for DENV-2
and DENV-3
The time to the most recent common ancestor (TMRCA)
was inferred using the Bayesian Markov Chain Monte
Carlo (MCMC) method implemented in the BEAST pack-
age v1.7.4 [46,47]. A GTR substitution model with gamma
distribution of rate variation among sites and a proportion
of invariable sites, an uncorrelated log-normal relaxed mo-
lecular clock model and a Bayesian skyline coalescent
model were used for this analysis. One hundred milliongenerations of MCMC chains were run with sampling at
every 10,000 generations. The MCMC output was
analysed using the Tracer Version 1.5 programme (http://
tree.bio.ed.ac.uk/software/tracer/). The uncertainty in par-
ameter estimates was expressed as 95% highest probability
density (HPD). All runs of MCMC were repeated to en-
sure convergence with effective sample size (ESS) of >200.
Test for selection pressure
Genome-wide dN/dS ratios were computed in Hyphy
2.1.2 standalone version [29] using the single likelihood
ancestor counting (SLAC), fixed effects likelihood (FEL),
internal fixed effects likelihood (IFEL) and the mixed ef-
fect model of evolution (MEME) methods [30]. The
Muse and Gaut (MG94) codon-based substitution model
and GTR-based maximum likelihood phylogeny with
gamma (4) distributed invariant sites, constructed using
MEGA 5 [45], were used and significance levels were set
at p<0.05.
Additional files
Additional file 1: Table S1. Information of the samples sequenced.
Additional file 2: Table S2. Serotype-specific primers used for
amplification and sequencing of the envelope protein gene.
Additional file 3: Table S3. Primers used for amplification and
sequencing of complete genome of DENV-2.
Additional file 4: Table S4. Primers used for amplification and
sequencing of complete genome of DENV-3.
Additional file 5: Table S5. Primers used for amplification and
sequencing of complete genome of DENV-4.
Additional file 6: Table S6. 5’& 3’UTR primers used for amplification
and sequencing of the complete genome of DENV.
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